Erlotinib hydrochloride and Platelet count - from FDA reports
Platelet count is reported only by a few people who take Erlotinib Hydrochloride. We study 4,447 people who have side effects while taking Erlotinib hydrochloride from FDA. Among them, 1 have Platelet count. Find out below who they are, when they have Platelet count and more.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Jul, 17, 2017
4,447 people reported to have side effects when taking Erlotinib hydrochloride.
Among them, 1 person (0.02%) has Platelet count
Number of reports submitted per year:
Time on Erlotinib hydrochloride when people have Platelet count *:
- < 1 month: 0.0 %
- 1 - 6 months: 100 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Platelet count when taking Erlotinib hydrochloride *:
- female: 100 %
- male: 0.0 %
Age of people who have Platelet count when taking Erlotinib hydrochloride *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Top conditions involved for these people *:
- Pancreatic Carcinoma (1 person, 100.00%)
Top co-used drugs for these people *:
- Gemcitabine (1 person, 100.00%)
Top other side effects for these people *:
- Malignant Neoplasm Progression (1 person, 100.00%)
- Hypoalbuminaemia (1 person, 100.00%)
- Hepatic Failure (1 person, 100.00%)
- Fever (1 person, 100.00%)
- Fatigue (1 person, 100.00%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have Platelet count when taking Erlotinib hydrochloride?
Expand the study to include all drugs with the same ingredientsPlatelet count and drugs with ingredients of erlotinib hydrochloride.
Erlotinib hydrochloride has active ingredients of erlotinib hydrochloride. (latest outcomes from Erlotinib hydrochloride 4,459 users)
Platelet count has been reported by people with idiopathic thrombocytopenic purpura, idiopathic thrombocytopenic purpura (itp), hepatitis c, high blood pressure, lung cancer - non-small cell (latest reports from 3,310 Platelet count patients).